Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 11, 2010 09:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Key 2010 Objectives

CAMBRIDGE, Mass., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today provided guidance on its...
January 11, 2010 08:43 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Updated Presentation Time at the J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the company has an...
January 07, 2010 15:32 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Presentations at January Conferences

CAMBRIDGE, Mass., Jan. 7, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that presentations will be...
December 07, 2009 06:30 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Names Adelene Q. Perkins Chief Executive Officer

Steven H. Holtzman to Serve as Executive Chair of the Board of Directors in Accordance With Existing Succession Plan Transition Strategically Positions Infinity for the...
November 17, 2009 08:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity's IPI-504 Named One of Windhover and Campbell Alliance's "Top 10 Projects to Watch" in Oncology

CAMBRIDGE, Mass., Nov. 17, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Jeffrey Tong, Ph.D.,...
November 16, 2009 09:30 ET | Source: Infinity Pharmaceuticals, Inc.

Adelene Q. Perkins Named "Best Executive" at Annual Stevie(R) Awards Ceremony

CAMBRIDGE, Mass., Nov. 16, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Adelene Q. Perkins,...
November 10, 2009 07:30 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity to Present at Upcoming Conferences

CAMBRIDGE, Mass., Nov. 10, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will...
November 09, 2009 16:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Reports Recent R&D Highlights and Third Quarter 2009 Results

-- Enrollment Open in All of Infinity's Ongoing Hsp90 Chaperone Inhibitor Studies -- Infinity Maintains Financial Strength to Advance Its Innovative Product Pipeline CAMBRIDGE,...
November 02, 2009 06:30 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Third Quarter 2009 Results Conference Call

CAMBRIDGE, Mass., Nov. 2, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that management will host...
October 07, 2009 07:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Appointment of Dr. Thomas J. Lynch to Its Board of Directors

CAMBRIDGE, Mass., Oct. 7, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that Thomas J. Lynch, Jr.,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right